Align Technology Inc Stock Price, News & Analysis

Align Technology reported Q2 2020 total revenues of $352.3 million, down 41.3% year-over-year. The GAAP net loss per diluted share was $(0.52), and non-GAAP net loss was $(0.35). Invisalign volume fell to 221.9 thousand cases, a 41.2% decrease. The company acquired exocad for $430 million, aiming to enhance its digital platform. Although practices are reopening, uncertainty around the pandemic's impact persists, leading to no guidance for Q3 2020.

Align Technology (Nasdaq: ALGN) announced the awarding of nine research grants as part of its Annual Research Award Program, reflecting growing global interest in dental and orthodontic treatments. The grants support various orthodontic research projects, validating the efficacy of the Invisalign system in clinical applications. Award recipients include institutions from North America, Europe, and Asia Pacific, addressing topics such as the effects of orthodontic appliances and treatment methodologies.

Align Technology will announce its second quarter 2020 financial results on July 22, 2020, after market close. The results will be available at 4:00 p.m. ET on their Investor Relations website. A conference call will follow at 4:30 p.m. ET to discuss the results. Investors can listen to the call live online and participate via phone. An archived audio webcast and telephonic replay will be available after the call. Align Technology is known for its Invisalign system and digital dental solutions, having treated over 8 million patients.

Align Technology has partnered with MedTech Innovator to support innovative medtech startups in the Asia Pacific region. The collaboration aims to mentor early to mid-stage companies selected for the 2020 Asia Pacific Showcase program. This initiative will award over $300,000 in prizes and support to promote advancements in patient care. Align’s commitment reflects its ongoing dedication to transforming orthodontic and restorative treatments through innovation.

Align Technology, Inc. (Nasdaq: ALGN) will present at two upcoming virtual financial conferences. The first is the Goldman Sachs 41st Annual Healthcare Conference on June 11, 2020, from 2:10 PM to 2:50 PM Eastern Time. The second is the Nasdaq 42nd London Investor Conference on June 17, 2020, from 1:00 PM to 1:50 PM BST. Both presentations can be accessed live via Align's Investor Relations website, with replays available for three months.

Align Technology has launched ClinCheck Pro 6.0, a cloud-based digital treatment planning software for Invisalign. This innovative software allows orthodontists to access treatment tools from any device, enhancing the patient experience through the new 'In-Face' Visualization feature. This feature merges photos of patients' faces with their 3D treatment plans, helping patients visualize their potential new smiles. ClinCheck Pro 6.0 promises easier doctor modifications and a more intuitive user experience. The software will be available starting in Q3 2020.

Align Technology (Nasdaq: ALGN) announced its participation in two upcoming virtual financial conferences. The UBS Global Healthcare Conference is scheduled for May 18, 2020, from 8:20 AM to 9:00 AM Eastern Time, featuring CFO John Morici. The Stifel Healthcare Conference will take place on May 27, 2020, from 1:50 PM to 2:20 PM Eastern Time, with CEO Joe Hogan and CFO John Morici as speakers. Live webcasts will be available on the company's investor relations website, with replays accessible for three months.

Align Technology, Inc. (NASDAQ: ALGN) has announced a change to its 2020 Annual Meeting of Stockholders due to the COVID-19 pandemic. The meeting will now take place on May 20, 2020, at 1:00 p.m. PDT, in a virtual-only format, changing from the previously scheduled time of 10:00 a.m. PDT. Stockholders as of March 25, 2020, can participate virtually and are encouraged to vote in advance using the previously distributed proxy card. A notification regarding this change will be filed with the SEC.

Align Technology, Inc. (NASDAQ: ALGN) has launched Invisalign Virtual Appointment and Invisalign Virtual Care solutions to enhance patient care amid the COVID-19 pandemic. These tools allow doctors to connect with patients remotely, facilitating continuity of care even when in-person appointments are not possible. The virtual appointment feature enables HIPAA-compliant video consultations, while the virtual care platform integrates with the My Invisalign app for monitoring treatment progress. Both services aim to improve patient experience and operational efficiencies for practices. The rollout began in March in the U.S. and Canada, with further expansion planned.